Regeneron Pharma (REGN) PT Raised to $540 at Argus
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $806.24 +1.03%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Regeneron Pharma (NASDAQ: REGN) to $540.00 (from $430.00) while maintaining a Buy rating.
You May Also Be Interested In
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
- JPMorgan Downgrades Computershare Limited (CPU:AU) (CMSQY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
